Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Bloomage Biotechnology (688363.SS)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (Rmb)	Price Target (Rmb)	Rating
2022-04-01	120.20	164.44	Neutral
2022-04-29	135.50	148.51	Neutral
2022-08-31	143.05	151.58	Neutral
2023-01-13	130.01	146.03	Neutral
2023-06-15	94.18	100.60	Neutral
2023-09-01	92.87	93.80	Neutral
2023-10-31	76.46	84.72	Neutral
2024-03-12	63.78	65.00	Neutral
2024-05-01	61.50	61.70	Neutral
2024-08-26	49.07	55.60	Neutral
2024-11-06	61.00	61.50	Neutral
2025-01-16	50.30	52.60	Neutral

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.